• 1. An antioxidative galactomannan extracted from Chinese Sesbania cannabina enhances immune activation of macrophage cells?
  Chongyang Zhu,Xiaojia Bian,Xin Jia,Ning Tang,Yongqiang Cheng Food Funct., 2020,11, 10635-10644
• 2. An aqueous ammonia sensor based on an inkjet-printed polyaniline nanoparticle-modified electrode
  Karl Crowley,Eimer O'Malley,Aoife Morrin,Malcolm R. Smyth,Anthony J. Killard Analyst, 2008,133, 391-399
• 3. An artificial CO-releasing metalloprotein built by histidine-selective metallation?
  Inês S. Albuquerque,Hélia F. Jeremias,Miguel Chaves-Ferreira,Dijana Matak-Vinkovic,Omar Boutureira,Carlos C. Rom?o Chem. Commun., 2015,51, 3993-3996
• 4. An autonomous self-optimizing flow machine for the synthesis of pyridine–oxazoline (PyOX) ligands?
  Eric Wimmer,Daniel Cortés-Borda,Solène Brochard,Elvina Barré,Charlotte Truchet,Fran?ois-Xavier Felpin React. Chem. Eng., 2019,4, 1608-1615
• 5. An alkynylboronatecycloaddition strategy to functionalised benzyne derivatives?
  James D. Kirkham,Patrick M. Delaney,George J. Ellames,Eleanor C. Row,Joseph P. A. Harrity Chem. Commun., 2010,46, 5154-5156

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Benzothiazoles Benzothiazoles
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Benzothiazoles

Introduction to 4-Chlorobenzo[d]thiazole-2-carbonitrile (CAS No. 1188232-19-0)

4-Chlorobenzo[d]thiazole-2-carbonitrile, identified by the Chemical Abstracts Service Number (CAS No.) 1188232-19-0, is a heterocyclic organic compound that has garnered significant attention in the field of pharmaceutical and agrochemical research. This compound belongs to the benzothiazole family, a class of molecules known for their diverse biological activities and structural versatility. The presence of both chloro and nitrile functional groups in its structure imparts unique reactivity, making it a valuable scaffold for synthesizing novel derivatives with potential therapeutic applications.

The benzothiazole core is a fused bicyclic system consisting of a benzene ring and a thiazole ring, which is characterized by the presence of sulfur and nitrogen atoms in the five-membered thiazole ring. This structural motif is widely recognized for its ability to interact with biological targets such as enzymes and receptors, thereby modulating various physiological processes. The introduction of a chloro substituent at the 4-position and a nitrile group at the 2-position further enhances the compound's pharmacological profile, enabling it to serve as a versatile building block for drug discovery efforts.

In recent years, there has been a surge in research focused on developing new therapeutic agents derived from benzothiazole derivatives. These compounds have shown promise in various preclinical studies, particularly in the treatment of inflammatory diseases, infectious disorders, and cancer. The4-Chlorobenzo[d]thiazole-2-carbonitrile structure has been explored as a precursor for synthesizing molecules that target specific enzymes involved in disease pathways. For instance, modifications to this scaffold have led to the development of inhibitors that modulate kinases and other signaling proteins critical for cellular processes.

One of the most compelling aspects of4-Chlorobenzo[d]thiazole-2-carbonitrile is its synthetic accessibility. The compound can be readily modified through various chemical transformations, allowing researchers to explore a wide range of structural variations. Functional group interconversions such as halogenation, nucleophilic substitution, and cyclization reactions can be employed to generate derivatives with tailored properties. This flexibility has enabled the creation of libraries of compounds that can be screened for biological activity using high-throughput screening (HTS) technologies.

The4-Chlorobenzo[d]thiazole-2-carbonitrile scaffold has also been investigated for its potential in developing agrochemicals. Benzothiazole derivatives exhibit herbicidal, fungicidal, and insecticidal properties, making them attractive candidates for crop protection applications. Researchers have leveraged the reactivity of the chloro and nitrile groups to design molecules that disrupt essential metabolic pathways in pests while minimizing toxicity to non-target organisms. This approach aligns with the growing demand for sustainable agricultural practices that reduce reliance on traditional pesticides.

Recent advances in computational chemistry have further accelerated the discovery process for4-Chlorobenzo[d]thiazole-2-carbonitrile-based compounds. Molecular modeling techniques allow researchers to predict binding interactions between these derivatives and biological targets with high accuracy. This has enabled the rational design of molecules with enhanced potency and selectivity. Additionally, machine learning algorithms are being employed to identify promising scaffolds from large chemical databases, streamlining the drug discovery pipeline.

The pharmacokinetic properties of4-Chlorobenzo[d]thiazole-2-carbonitrile and its derivatives are also areas of active investigation. Understanding how these compounds are absorbed, distributed, metabolized, and excreted (ADME) is crucial for optimizing their therapeutic efficacy. Preclinical studies have provided insights into the metabolic pathways involved in the biotransformation of benzothiazole derivatives, which can inform dosing regimens and minimize potential side effects.

In conclusion,4-Chlorobenzo[d]thiazole-2-carbonitrile (CAS No. 1188232-19-0) represents a promising scaffold for developing novel pharmaceuticals and agrochemicals. Its unique structural features and synthetic versatility make it an attractive candidate for further exploration in drug discovery efforts. As research continues to uncover new biological activities associated with benzothiazole derivatives,4-Chlorobenzo[d]thiazole-2-carbonitrile is poised to play a significant role in addressing unmet medical needs across multiple therapeutic areas.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)